Clues to prognosis in multiple sclerosis found in the blood

Ian Fyfe¹

Affiliations

Comment

Ian Fyfe. Nat Rev Neurol. 2020 Jul.

. 2020 Jul;16(7):349.

doi: 10.1038/s41582-020-0376-9.

Ian Fyfe¹

No abstract available

Comment on

Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients.
Zanoni M, Orlandi E, Rossetti G, Turatti M, Calabrese M, Gomez Lira M, Gajofatto A. Zanoni M, et al. Acta Neurol Scand. 2020 Nov;142(5):511-516. doi: 10.1111/ane.13288. Epub 2020 Jun 5. Acta Neurol Scand. 2020. PMID: 32432792
Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis.
Manouchehrinia A, Stridh P, Khademi M, Leppert D, Barro C, Michalak Z, Benkert P, Lycke J, Alfredsson L, Kappos L, Piehl F, Olsson T, Kuhle J, Kockum I. Manouchehrinia A, et al. Neurology. 2020 Jun 9;94(23):e2457-e2467. doi: 10.1212/WNL.0000000000009571. Epub 2020 May 20. Neurology. 2020. PMID: 32434867 Free PMC article.

1. Zanoni, M. et al. Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients. Acta Neurol. Scand. https://doi.org/10.1111/ane.13288 (2020)
1. Manouchehrinia, A. et al. Plasma neurofilament light levels are associated with the risk of disability in multiple sclerosis. Neurology https://doi.org/10.1212/WNL.0000000000009571 (2020)

1. Khalil, M. et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol. 14, 577–589 (2018) - DOI